Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-α2a for patients with advanced renal cell carcinoma.
Journal of Interferon and Cytokine Research.
Times cited: 86
Phase I study of recombinant human interleukin-1β(rhIL-1β) in patients with bone marrow failure.
Bone Marrow Transplantation.
Times cited: 11